Skip to Content


Active Substance: recombinant salmon calcitonin (rsct)
Common Name: recombinant salmon calcitonin
ATC Code: H05BA01
Marketing Authorisation Holder: Unigene UK Ltd.
Active Substance: recombinant salmon calcitonin (rsct)
Status: Withdrawn
Authorisation Date: 1999-01-11
Therapeutic Area: Hypercalcemia Osteitis Deformans Bone Resorption
Pharmacotherapeutic Group: Calcium homeostasis

Therapeutic Indication

Calcitonin is indicated for:
• Prevention of acute bone loss due to sudden immobilisation such as in patients with recent
osteoporotic fractures
• Paget's disease
• Hypercalcaemia of malignancy

The marketing authorisation for Forcaltonin has been withdrawn at the request of the marketing authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.